{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-116103","form_type":"8-K","ticker":"NDRA","cik":"0001681682","company_name":"ENDRA Life Sciences Inc.","filed_at":"2025-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.135631+00:00","generated_at":"2026-05-16T16:11:46.539510+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ENDRA Life Sciences CTO Resigns, Enters Consulting Agreement; CFO Services Formalized","bullets":["Michael Thornton resigned as CTO effective Nov 28, 2025; entered Consulting Agreement at $150/hr (first 5 hrs/week) then $100/hr.","Richard Jacroux continues as CFO via Impact Solve LLC; initial monthly fee $8,650 increasing to $10,800 from Jan 1, 2026.","Thornton's outstanding Options and RSUs remain outstanding and continue to vest during the consulting term.","Impact Solve Advisory Services Agreement replaces prior services agreement for CFO duties."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-116103","json":"https://secwatch.observer/filing/0001213900-25-116103.json","markdown":"https://secwatch.observer/filing/0001213900-25-116103.md","text":"https://secwatch.observer/filing/0001213900-25-116103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1681682/000121390025116103/0001213900-25-116103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1681682/000121390025116103/ea0267731-8k_endra.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T16:11:46.539510+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}